Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on Hidradenitis Suppurativa (HS) Burden of Illness and Health Care Resources Utilization

NCT02896920 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02896920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02896920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on Hidradenitis Suppurativa (HS) Burden of Illness and Health Care Resources Utilization
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
September 20, 2016
Completion date
April 29, 2019
Enrollment
165 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (hs)